Sartorius Stedim Biotech S.A. SDMHF
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | 32.68% | -21.36% | |
| Total Depreciation and Amortization | -- | -- | 5.19% | 12.43% | |
| Total Amortization of Deferred Charges | -- | -- | 77.05% | 77.05% | |
| Total Other Non-Cash Items | -- | -- | 73.29% | 405.81% | |
| Change in Net Operating Assets | -- | -- | -26.80% | 42.23% | |
| Cash from Operations | -- | -- | 12.33% | 37.55% | |
| Capital Expenditure | -- | -- | 26.85% | 37.31% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 84.85% | 97.60% | |
| Cash from Investing | -- | -- | 88.84% | 89.24% | |
| Total Debt Issued | -- | -- | -99.32% | -99.30% | |
| Total Debt Repaid | -- | -- | 95.44% | 60.73% | |
| Issuance of Common Stock | -- | -- | -99.41% | -99.51% | |
| Repurchase of Common Stock | -- | -- | 66.10% | -426.67% | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -5.44% | -- | |
| Other Financing Activities | -- | -- | -8.34% | -49.79% | |
| Cash from Financing | -- | -- | -111.13% | -121.22% | |
| Foreign Exchange rate Adjustments | -- | -- | 84.91% | 286.37% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -107.64% | -51.63% | |
| Net Change in Cash | -- | -- | -30.41% | -98.24% | |